These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 9533847
1. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175. Sato S, Mori K, Wyman M, Kador PF. Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847 [Abstract] [Full Text] [Related]
2. Progression of sugar cataract in the dog. Sato S, Takahashi Y, Wyman M, Kador PF. Invest Ophthalmol Vis Sci; 1991 May; 32(6):1925-31. PubMed ID: 1903366 [Abstract] [Full Text] [Related]
3. Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose. Kador PF, Betts D, Wyman M, Blessing K, Randazzo J. Am J Vet Res; 2006 Oct; 67(10):1783-7. PubMed ID: 17014334 [Abstract] [Full Text] [Related]
4. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study. Datiles M, Fukui H, Kuwabara T, Kinoshita JH. Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419 [Abstract] [Full Text] [Related]
5. Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175. Neuenschwander H, Takahashi Y, Kador PF. J Ocul Pharmacol Ther; 1997 Dec; 13(6):517-28. PubMed ID: 9436155 [Abstract] [Full Text] [Related]
7. Aldose reductase inhibitors and prevention of galactose cataracts in rats. Unakar N, Tsui J, Johnson M. Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646 [Abstract] [Full Text] [Related]
11. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs. Datiles MB, Kador PF, Kashima K, Kinoshita JH, Sinha A. Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961 [Abstract] [Full Text] [Related]
18. Cataract formation through the polyol pathway is associated with free radical production. Kubo E, Miyoshi N, Fukuda M, Akagi Y. Exp Eye Res; 1999 Apr; 68(4):457-64. PubMed ID: 10192803 [Abstract] [Full Text] [Related]
19. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH. Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169 [Abstract] [Full Text] [Related]
20. Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts. Kador PF, Randazzo J, Babb T, Koushik K, Takamura Y, Zhu W, Blessing K, Kompella UB. J Ocul Pharmacol Ther; 2007 Apr; 23(2):116-23. PubMed ID: 17444799 [Abstract] [Full Text] [Related] Page: [Next] [New Search]